Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Reumatologia Clinica
|
July 29, 2011
[Treatment of Gout: Reflections From the GEMA Study]
Fernando Pérez Ruiz
Clinical Rheumatology
|
August 18, 2019
Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients
María Presa, Fernando Pérez-Ruiz, Itziar Oyagüez
Nature Reviews. Rheumatology
|
September 8, 2023
Mechanisms and rationale for uricase use in patients with gout
Naomi Schlesinger, Fernando Pérez-Ruiz, Frédéric Lioté
Reumatologia Clinica
|
July 29, 2011
[Influence of the natural history of disease on a previous diagnosis in patients with gout]
Fernando Pérez Ruiz, Jesús Ruiz López, Ana María Herrero Beites
Medicina Clinica
|
February 18, 2022
Gout. What's up doc?
Fernando Pérez Ruiz, Nuria Pérez Herrero, María Ángeles Gantes Pedraza
Reumatologia Clinica
|
May 14, 2013
Osteomalacia induced by adefovir in patient with hepatitis B
Mayra Nathali Rivas Zavaleta, Sonia Guayambuco Romero, Marcelo Calabozo Raluy, et al.
Rheumatology International
|
December 19, 2014
Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis
Isabel Castrejon, Esther Toledano, María Piedad Rosario, et al.
Drugs in Context
|
June 14, 2019
Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
Fernando Pérez-Ruiz, Tim Jansen, Anne-Katrin Tausche, et al.
RMD Open
|
November 2, 2019
Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality
Fernando Pérez Ruiz, Pascal Richette, Austin G Stack, et al.
Joint Bone Spine
|
July 29, 2021
Prevalence of gout in the adult general population in Spain: Estimating the proportion of undiagnosed cases
Neus Quilis, Francisca Sivera, Daniel Seoane-Mato, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Reumatologia Clinica
|
July 29, 2011
[Treatment of Gout: Reflections From the GEMA Study]
Fernando Pérez Ruiz
Clinical Rheumatology
|
August 18, 2019
Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients
María Presa, Fernando Pérez-Ruiz, Itziar Oyagüez
Nature Reviews. Rheumatology
|
September 8, 2023
Mechanisms and rationale for uricase use in patients with gout
Naomi Schlesinger, Fernando Pérez-Ruiz, Frédéric Lioté
Reumatologia Clinica
|
July 29, 2011
[Influence of the natural history of disease on a previous diagnosis in patients with gout]
Fernando Pérez Ruiz, Jesús Ruiz López, Ana María Herrero Beites
Medicina Clinica
|
February 18, 2022
Gout. What's up doc?
Fernando Pérez Ruiz, Nuria Pérez Herrero, María Ángeles Gantes Pedraza
Reumatologia Clinica
|
May 14, 2013
Osteomalacia induced by adefovir in patient with hepatitis B
Mayra Nathali Rivas Zavaleta, Sonia Guayambuco Romero, Marcelo Calabozo Raluy, et al.
Rheumatology International
|
December 19, 2014
Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis
Isabel Castrejon, Esther Toledano, María Piedad Rosario, et al.
Drugs in Context
|
June 14, 2019
Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
Fernando Pérez-Ruiz, Tim Jansen, Anne-Katrin Tausche, et al.
RMD Open
|
November 2, 2019
Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality
Fernando Pérez Ruiz, Pascal Richette, Austin G Stack, et al.
Joint Bone Spine
|
July 29, 2021
Prevalence of gout in the adult general population in Spain: Estimating the proportion of undiagnosed cases
Neus Quilis, Francisca Sivera, Daniel Seoane-Mato, et al.
Page
of 2